Cargando…

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

We analyze the impact of cyclosporine (CsA) levels in the development of acute graft-versus-host disease (aGVHD) after reduced intensity conditioning allogeneic hematopoietic transplantation (allo-RIC). We retrospectively evaluated 156 consecutive patients who underwent HLA-identical sibling allo-RI...

Descripción completa

Detalles Bibliográficos
Autores principales:	García Cadenas, Irene, Valcarcel, David, Martino, Rodrigo, Piñana, J. L., Barba, Pere, Novelli, Silvana, Esquirol, Albert, Garrido, Ana, Saavedra, Silvana, Granell, Miquel, Moreno, Carol, Briones, Javier, Brunet, Salut, Sierra, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929065/ https://www.ncbi.nlm.nih.gov/pubmed/24623962 http://dx.doi.org/10.1155/2014/620682

Ejemplares similares

Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
por: Irene, García-Cadenas, et al.
Publicado: (2020)

T-Cell Costimulatory Molecules in Acute-Graft-Versus Host Disease: Therapeutic Implications
por: Briones, Javier, et al.
Publicado: (2011)

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT
por: Martino, R, et al.
Publicado: (2009)

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
por: Martino, Rodrigo, et al.
Publicado: (2021)

Epidemiology of lymphoid malignancies: last decade update
por: Novelli, Silvana, et al.
Publicado: (2013)

mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature
por: Albiol, Nil, et al.
Publicado: (2021)

Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation
por: Caballero, Ana, et al.
Publicado: (2019)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
por: Roldan, Elisa, et al.
Publicado: (2019)

Influence of Lactate Dehydrogenase and Cyclosporine A Level on the Incidence of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
por: Song, Moo-Kon, et al.
Publicado: (2009)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Frequency and Risk Factors of Cyclosporine-Induced Neurotoxicity in Allogeneic Stem Cell Transplant Recipients
por: Danish, Asma, et al.
Publicado: (2021)

Fatal Strongyloides Hyperinfection Complicating a Gram-Negative Sepsis after Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature
por: Izquierdo, Isabel, et al.
Publicado: (2013)

Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
por: Rey-Búa, Beatriz, et al.
Publicado: (2022)

Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: a systematic review
por: da Silva, Juliana Bastoni, et al.
Publicado: (2014)

Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties
por: Timrott, Kai, et al.
Publicado: (2015)

A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Tavakoli Ardakani, Maria, et al.
Publicado: (2016)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia
por: Martino, R, et al.
Publicado: (1998)

Improved patient and graft survival using cyclosporin A in cadaver renal transplantation
por: Johnson, R W G
Publicado: (1985)

Low cyclosporine concentrations in children and time to acute graft versus host disease
por: Chung, Eun Kyung, et al.
Publicado: (2020)

P1420: COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTATION OF SICKLE CELL DISEASE
por: Alfaqawi, Samar, et al.
Publicado: (2023)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Esquirol, Albert, et al.
Publicado: (2021)

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018)

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
por: Gutierrez, Antonio, et al.
Publicado: (2022)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation
por: de Kort, Elizabeth A., et al.
Publicado: (2019)

Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease.
por: Denham, S., et al.
Publicado: (1983)

Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease
Publicado: (1989)

Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice
por: Liu, Yong, et al.
Publicado: (2012)

Natural Killer Cells Promote Kidney Graft Rejection Independently of Cyclosporine A Therapy
por: Ashraf, Muhammad Imtiaz, et al.
Publicado: (2019)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Is Cyclosporine Ototoxic?
por: Waissbluth, Sofia
Publicado: (2020)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation
por: Park, Silvia, et al.
Publicado: (2016)

Estimation of Abbreviated Cyclosporine A Area under the Concentration-Time Curve in Allogenic Stem Cell Transplantation after Oral Administration
por: ELjebari, Hanene, et al.
Publicado: (2012)

Cyclosporin A in clinical organ grafting. First Northern Ireland Kidney Research Fund lecture.
por: Calne, R. Y., et al.
Publicado: (1981)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6iefn4r3sks94826alnphp66ea